Skip to main content
. 2021 Apr 20;11:629333. doi: 10.3389/fonc.2021.629333

Figure 6.

Figure 6

OLR1 may affect the clinical benefits to immunotherapy in NSCLC patients. (A) The comparison of responder number in top or bottom OLR1 expression samples. (B–E) OLR1 has strong positive correlation with some indicators of TIDE prediction.